Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

EGFR mutations are significantly associated with visceral pleural invasion development in non-small-cell lung cancer patients.

Shi J, Yang Y, Zhao Y, Zhu J, Song X, Jiang G.

Cancer Manag Res. 2019 Mar 1;11:1945-1957. doi: 10.2147/CMAR.S195747. eCollection 2019.

2.

Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer.

Seok Y, Jeong JY, Lee E.

Thorac Cancer. 2017 May;8(3):197-202. doi: 10.1111/1759-7714.12424. Epub 2017 Feb 21.

3.

Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm.

Chen T, Luo J, Wang R, Gu H, Gu Y, Huang Q, Wang Y, Zheng J, Gu C, Pan X, Yang J, Yang Y, Zhao H.

Oncotarget. 2017 Mar 22;8(39):66576-66583. doi: 10.18632/oncotarget.16476. eCollection 2017 Sep 12.

4.

Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.

Tian D, Pei Y, Zheng Q, Zhang J, Li S, Wang X, Lin D, Yang Y.

Thorac Cancer. 2017 Mar;8(2):97-105. doi: 10.1111/1759-7714.12412. Epub 2017 Feb 3.

5.

Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.

Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G.

Eur J Cardiothorac Surg. 2013 Sep;44(3):e200-6. doi: 10.1093/ejcts/ezt309. Epub 2013 Jun 13.

PMID:
23766428
6.

Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.

Manac'h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C.

Ann Thorac Surg. 2001 Apr;71(4):1088-93.

PMID:
11308141
7.

Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.

David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ.

Ann Thorac Surg. 2013 Jun;95(6):1872-7; discussion 1877. doi: 10.1016/j.athoracsur.2013.03.085. Epub 2013 May 2.

8.

Novel biologic factors correlated to visceral pleural invasion in early-stage non-small cell lung cancer less than 3 cm.

Deng HY, Li G, Luo J, Alai G, Zhuo ZG, Lin YD.

J Thorac Dis. 2018 Apr;10(4):2357-2364. doi: 10.21037/jtd.2018.03.185.

9.

Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.

Tao H, Hayashi T, Sano F, Takahagi A, Tanaka T, Matsuda E, Okabe K.

J Surg Res. 2013 Nov;185(1):250-4. doi: 10.1016/j.jss.2013.05.104. Epub 2013 Jun 22.

PMID:
23830361
10.

Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.

Neri S, Yoshida J, Ishii G, Matsumura Y, Aokage K, Hishida T, Nagai K.

Ann Surg. 2014 Aug;260(2):383-8. doi: 10.1097/SLA.0000000000000617.

PMID:
24646539
11.

Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura.

Le H, Wang X, Zha Y, Wang J, Zhu W, Ye Z, Liu X, Ma H, Zhang Y.

Oncol Lett. 2017 Dec;14(6):7931-7940. doi: 10.3892/ol.2017.7195. Epub 2017 Oct 16.

12.

Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.

Wang S, Zhang B, Qian J, Qiao R, Xu J, Zhang L, Zhao Y, Zhang Y, Wang R, Zhao R, Han B.

Lung Cancer. 2018 Nov;125:245-252. doi: 10.1016/j.lungcan.2018.09.024. Epub 2018 Oct 1.

PMID:
30429028
13.

The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.

Jiang L, Liang W, Shen J, Chen X, Shi X, He J, Yang C, He J.

Chest. 2015 Oct;148(4):903-911. doi: 10.1378/chest.14-2765. Review.

PMID:
25675151
14.

The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas.

Zhang H, Lu C, Lu Y, Yu B, Lv F, Zhu Z.

Onco Targets Ther. 2016 Apr 20;9:2337-48. doi: 10.2147/OTT.S100965. eCollection 2016.

15.

Influence of visceral pleural invasion on survival in completely resected non-small-cell lung cancer.

Adachi H, Tsuboi M, Nishii T, Yamamoto T, Nagashima T, Ando K, Ishikawa Y, Woo T, Watanabe K, Kumakiri Y, Maehara T, Morohoshi T, Nakayama H, Masuda M.

Eur J Cardiothorac Surg. 2015 Nov;48(5):691-7; discussion 697. doi: 10.1093/ejcts/ezu515. Epub 2015 Jan 5.

PMID:
25564209
16.

Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.

Wo Y, Zhao Y, Qiu T, Li S, Wang Y, Lu T, Qin Y, Song G, Miao S, Sun X, Liu A, Kong D, Dong Y, Leng X, Du W, Jiao W.

Cancer Med. 2019 Feb;8(2):669-678. doi: 10.1002/cam4.1990. Epub 2019 Feb 1.

17.

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis.

Zhang SM, Zhu QG, Ding XX, Lin S, Zhao J, Guan L, Li T, He B, Zhang HQ.

Cancer Manag Res. 2018 Sep 10;10:3393-3404. doi: 10.2147/CMAR.S167578. eCollection 2018.

18.

Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer.

Kudo Y, Saji H, Shimada Y, Nomura M, Matsubayashi J, Nagao T, Kakihana M, Usuda J, Kajiwara N, Ohira T, Ikeda N.

Lung Cancer. 2012 Nov;78(2):153-60. doi: 10.1016/j.lungcan.2012.08.004. Epub 2012 Sep 1.

PMID:
22944144
20.

[Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].

Su XD, Long H, Wang X, Fu JH, He JH, Lin P, Zhang LJ, Ma GW.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):368-71. Chinese.

PMID:
18953838

Supplemental Content

Support Center